NO892387L - Propanolaminderivater. - Google Patents

Propanolaminderivater.

Info

Publication number
NO892387L
NO892387L NO89892387A NO892387A NO892387L NO 892387 L NO892387 L NO 892387L NO 89892387 A NO89892387 A NO 89892387A NO 892387 A NO892387 A NO 892387A NO 892387 L NO892387 L NO 892387L
Authority
NO
Norway
Prior art keywords
propanolamides
diabetes
reduction
prepared
formula
Prior art date
Application number
NO89892387A
Other languages
English (en)
Other versions
NO170011C (no
NO170011B (no
NO892387D0 (no
Inventor
Frank Kienzle
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO892387D0 publication Critical patent/NO892387D0/no
Publication of NO892387L publication Critical patent/NO892387L/no
Publication of NO170011B publication Critical patent/NO170011B/no
Publication of NO170011C publication Critical patent/NO170011C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/52Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
  • Glass Compositions (AREA)
  • Gyroscopes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
NO892387A 1988-06-10 1989-06-09 Analogifremgangsmaate til fremstilling av propanolaminderivater NO170011C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH224588 1988-06-10

Publications (4)

Publication Number Publication Date
NO892387D0 NO892387D0 (no) 1989-06-09
NO892387L true NO892387L (no) 1989-12-11
NO170011B NO170011B (no) 1992-05-25
NO170011C NO170011C (no) 1992-09-02

Family

ID=4229254

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892387A NO170011C (no) 1988-06-10 1989-06-09 Analogifremgangsmaate til fremstilling av propanolaminderivater

Country Status (20)

Country Link
US (1) US5045567A (no)
EP (1) EP0345591B1 (no)
JP (1) JPH0236158A (no)
KR (1) KR910000600A (no)
AT (1) ATE87610T1 (no)
AU (1) AU622907B2 (no)
DE (1) DE58903919D1 (no)
DK (1) DK284289A (no)
ES (1) ES2053866T3 (no)
FI (1) FI892341A (no)
HU (1) HUT55344A (no)
IE (1) IE891855L (no)
IL (1) IL90528A0 (no)
MC (1) MC2042A1 (no)
NO (1) NO170011C (no)
NZ (1) NZ229456A (no)
PH (1) PH26237A (no)
PT (1) PT90802B (no)
YU (1) YU118389A (no)
ZA (1) ZA894210B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
DK0869121T3 (da) * 1997-04-04 2004-09-20 Aventis Pharma Gmbh Hypolipidæmiske propanolaminderivater
DE19845405C2 (de) * 1998-10-02 2000-07-13 Aventis Pharma Gmbh Arylsubstituierte Propanolaminderivate und deren Verwendung
DE19845403B4 (de) * 1998-10-02 2005-02-10 Aventis Pharma Deutschland Gmbh Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7112938A (no) * 1970-09-30 1972-04-05
NL7208391A (no) * 1971-06-25 1972-12-28
DK268779A (da) * 1978-07-03 1980-01-04 Lilly Co Eli Fremgangsmaade til fremstilling af phenethanolaminer
DE3267406D1 (en) * 1981-07-11 1985-12-19 Beecham Group Plc Secondary phenyl ethanol amines and their pharmaceutical use
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
WO1984000956A1 (en) * 1982-08-27 1984-03-15 Beecham Group Plc Secondary arylethanolamines
DE3462789D1 (en) * 1983-08-17 1987-04-30 Beecham Group Plc 2-phenylethylamine derivatives
DE3466387D1 (en) * 1983-11-04 1987-10-29 Beecham Group Plc Tertiary amines
CA1249992A (en) * 1983-11-10 1989-02-14 Marcel Muller Oxazolidines
FR2588556B1 (fr) * 1985-10-11 1988-01-08 Sanofi Sa Derives du naphtalene substitues par un groupement (omega-amino) alcanol a activite antimicrobienne, leur preparation et les compositions les contenant
CA1287061C (en) * 1986-06-27 1991-07-30 Roche Holding Ltd. Pyridine ethanolamine derivatives
DE3866984D1 (en) * 1987-07-21 1992-01-30 Hoffmann La Roche Phenoxypropanolamine.

Also Published As

Publication number Publication date
US5045567A (en) 1991-09-03
DK284289A (da) 1989-12-11
FI892341A (fi) 1989-12-11
EP0345591B1 (de) 1993-03-31
DK284289D0 (da) 1989-06-09
PT90802A (pt) 1989-12-29
KR910000600A (ko) 1991-01-29
AU3602689A (en) 1989-12-14
ES2053866T3 (es) 1994-08-01
ATE87610T1 (de) 1993-04-15
AU622907B2 (en) 1992-04-30
MC2042A1 (fr) 1990-05-30
NO170011C (no) 1992-09-02
ZA894210B (en) 1990-03-28
IE891855L (en) 1989-12-10
IL90528A0 (en) 1990-01-18
FI892341A0 (fi) 1989-05-16
JPH0236158A (ja) 1990-02-06
NO170011B (no) 1992-05-25
HUT55344A (en) 1991-05-28
YU118389A (en) 1991-06-30
NZ229456A (en) 1992-02-25
NO892387D0 (no) 1989-06-09
PT90802B (pt) 1994-11-30
EP0345591A1 (de) 1989-12-13
DE58903919D1 (en) 1993-05-06
PH26237A (en) 1992-04-01

Similar Documents

Publication Publication Date Title
MC1831A1 (fr) Derives de pyridine-ethalolamine
ES2167338T3 (es) Composicion para tratar pacientes con enfermedades hepaticas.
IE39095L (en) Feed additive for ruminants.
NZ191867A (en) N1,n1,2,3,4,5,6-substituted-1-piperazine-carboxamides and carbothioamides
DK0539448T3 (da) Levnedsmiddelsammensætninger og farmaceutiske sammensætninger indeholdende kortkædede, monoumættede fedtsyrer og fremgangsmåde til anvendelse
ES2062239T3 (es) Diamidas de acidos pirimidin-4,6-dicarboxilicos, procedimiento para su preparacion, utilizacion de las mismas, asi como medicamentos a base de estos compuestos.
IE810391L (en) Trihydroxypiperidine derivatives.
BR0102134A (pt) Composição para ração para um animal de criação, ração, e, método para aumentar a eficiência de ganho de peso corpóreo e a eficiência de ração do animal de criação
ES2053866T3 (es) Derivados propanolaminicos.
KR850005234A (ko) 사료첨가 조성물
IE880628L (en) Substituted pyridine-2,4-dicarboxylic acid derivatives,¹processes for their preparation, the use thereof and¹medicaments based on these compounds
ATE3033T1 (de) Derivate des 2-hydroxymethyl-3,4,5-trihydroxypiperidins, ihre herstellung und sie enthaltende arzneimittel.
EP0386603A3 (de) Bisphenäthanolamine
KR890701028A (ko) 살코기 생산 동물에 대한 피롤리마이신 성장 향상제
GB1426778A (en) Method of treating livestock
UA22101A (uk) Кормова добавка для жуйних твариh